Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,408.50
(
-1.24%
)
US TECH 100
28,327.60
(
-0.10%
)
Dow Jones
49,526.17
(
-1.07%
)
Brent Oil
107.12
(
-0.33%
)
Bitcoin
76,828.99
(
-0.75%
)
News Focus
News Focus
Post# of 257580
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122988
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: biomaven0 post# 94844

Tuesday, 04/27/2010 6:15:37 PM

Tuesday, April 27, 2010 6:15:37 PM

Post# of 257580
I would think a boutique drug-discovery outfit such as IDIX could do each of these tasks except #1, which requires a comprehensive compound library.

At some point, we ought to see some discussion of what NS5A does for the HCV virus. Was this addressed in the article you read? In any case, I’d be interested in reading the article you read about BMS-790052. T.i.a. for a link, email, or any other reference you may have.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today